Hersh Kozlov, Director at vTv Therapeutics Inc. (VTVT), bought 5,000 shares at $1.65 ($8K) on 2019-09-13, disclosed to the SEC on 2019-09-17.
Open-market purchase of $8k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| VTVT | BUY | 2020-05-18 | $30K | — | Filing → |
| TBBK | SELL | 2018-03-01 | $53K | — | Filing → |
| TBBK | SELL | 2018-02-15 | $53K | — | Filing → |